ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 84 filers reported holding ITEOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $386,754 | -21.2% | 35,320 | -4.7% | 0.00% | – |
Q2 2023 | $490,674 | +42.5% | 37,060 | +46.5% | 0.00% | – |
Q1 2023 | $344,333 | -39.0% | 25,300 | -12.5% | 0.00% | – |
Q4 2022 | $564,847 | -59.2% | 28,922 | -60.3% | 0.00% | -100.0% |
Q3 2022 | $1,386,000 | -89.3% | 72,779 | -88.5% | 0.00% | -83.3% |
Q2 2022 | $13,001,000 | -63.8% | 631,118 | -43.5% | 0.01% | -57.1% |
Q1 2022 | $35,956,000 | -40.8% | 1,117,346 | -14.4% | 0.01% | -33.3% |
Q4 2021 | $60,771,000 | +68.6% | 1,305,213 | -2.2% | 0.02% | +50.0% |
Q3 2021 | $36,047,000 | +3.7% | 1,335,081 | -1.5% | 0.01% | 0.0% |
Q2 2021 | $34,758,000 | -13.1% | 1,355,078 | +15.8% | 0.01% | -22.2% |
Q1 2021 | $39,991,000 | +7.7% | 1,170,001 | +6.5% | 0.02% | 0.0% |
Q4 2020 | $37,138,000 | +96.0% | 1,098,100 | +43.0% | 0.02% | +80.0% |
Q3 2020 | $18,949,000 | – | 768,084 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |